Your browser doesn't support javascript.
loading
Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data.
Lötsch, Felix; Naderer, Judith; Skuhala, Tomislava; Groger, Mirjam; Auer, Herbert; Kaczirek, Klaus; Waneck, Fredrik; Ramharter, Michael.
Affiliation
  • Lötsch F; Division of Infectious Diseases and Tropical Medicine Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Naderer J; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
  • Skuhala T; Division of Infectious Diseases and Tropical Medicine Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Groger M; University Hospital for Infectious Diseases Fran Mihaljevic, Zagreb, Croatia.
  • Auer H; Division of Infectious Diseases and Tropical Medicine Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Kaczirek K; Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
  • Waneck F; Department of Medical Parasitology, Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
  • Ramharter M; Department of Surgery, Medical University of Vienna, Vienna, Austria.
Parasitol Res ; 115(8): 2995-3001, 2016 Aug.
Article de En | MEDLINE | ID: mdl-27085708
ABSTRACT
Cystic echinococcosis (CE) is a widespread zoonosis caused by the species complex Echinococcus granulosus. Albendazole (ABZ)-the first-line anthelminthic drug for medical treatment of CE-is metabolized in vivo to the active derivative ABZ-sulphoxide (ABZ-SO). Target-site ABZ-SO concentrations in the hydatid cyst mediate the anthelminthic effect in CE. Primary outcome of this systematic review of individual patient data was the intra-cystic ABZ-SO concentration stratified by cyst size, location, calcification status and use of praziquantel. Studies reporting intra-cystic ABZ-SO concentrations in humans were identified by a systematic search. A pooled analysis of individual patient data was performed to assess intra-cystic concentrations. Pharmacokinetic data of 121 individual cysts were analysed. There was no correlation between plasma and intra-cystic ABZ-SO concentrations (rho = -0.03, p = 0.76). Intra-cystic drug concentrations were also not associated with sex and treatment duration. Use of praziquantel in combination with ABZ was associated with higher plasma (median 540 vs. 240 µg/L; p = 0.04) but not intra-cystic ABZ-SO concentrations (median 220 vs. 199 µg/L; p = 0.36). Relative drug concentrations in hepatic cysts were higher than in other cysts (0.8 vs. 0.4; p = 0.05). Intra-cystic concentrations were higher in calcified than non-calcified cysts (median 897 vs. 245 µg/L; p = 0.03). There was a trend towards higher intra-cystic concentrations in smaller sized cysts (ß = -17.2 µg/L/cm; 95th CI, -35.9 to 1.6; p = 0.07). This study demonstrates that mean intra-cystic drug concentrations are similar to plasma concentrations on a population level. However, in individual patients plasma concentrations are not directly predictive for intra-cystic concentrations. The use of booster drugs was not associated with higher intra-cystic ABZ-SO concentrations in this analysis.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Albendazole / Echinococcus granulosus / Échinococcose / Anthelminthiques Type d'étude: Prognostic_studies / Systematic_reviews Limites: Animals / Humans Langue: En Journal: Parasitol Res Sujet du journal: PARASITOLOGIA Année: 2016 Type de document: Article Pays d'affiliation: Autriche

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Albendazole / Echinococcus granulosus / Échinococcose / Anthelminthiques Type d'étude: Prognostic_studies / Systematic_reviews Limites: Animals / Humans Langue: En Journal: Parasitol Res Sujet du journal: PARASITOLOGIA Année: 2016 Type de document: Article Pays d'affiliation: Autriche